Strategic corporate responsibility orientation for sustainable global health governance: pharmaceutical value co-protection in transitioning economies
| Data(s) |
26/05/2015
26/05/2015
05/06/2015
|
|---|---|
| Identificador |
http://www.doria.fi/handle/10024/104863 URN:ISBN:978-952-249-436-8 |
| Idioma(s) |
en |
| Tipo |
Doctoral Dissertation (Article based) |